Gene mutations independent of BCR::ABL1 have been identified in newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase, whereby mutations in epigenetic modifier genes were most common. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.